These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 215232

  • 1. Plasminogen activator from cells transformed by an oncogenic virus: inhibitors of the activation reaction.
    Danø K, Reich E.
    Biochim Biophys Acta; 1979 Jan 12; 566(1):138-51. PubMed ID: 215232
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of a plasminogen activator from oncogenic virus-transformed mouse cells by rabbit antibodies against the enzyme.
    Danø K, Nielsen LS, Møller V, Engelhart M.
    Biochim Biophys Acta; 1980 Jun 05; 630(1):146-51. PubMed ID: 6248125
    [Abstract] [Full Text] [Related]

  • 3. A direct, plasmin-independent assay for plasminogen activator.
    Mussoni L, Lawrence D, Loskutoff DJ.
    Thromb Res; 1984 May 01; 34(3):241-54. PubMed ID: 6233750
    [Abstract] [Full Text] [Related]

  • 4. Expression of the catalytic activity of plasminogen activator under physiologic conditions.
    Aggeler J, Risch J, Werb Z.
    Biochim Biophys Acta; 1981 Jun 11; 675(1):62-8. PubMed ID: 6455162
    [Abstract] [Full Text] [Related]

  • 5. The plasma inhibitors of plasminogen activator, studied by a zymographic technique.
    Booth NA, Anderson JA, Bennett B.
    Thromb Res; 1985 May 01; 38(3):261-7. PubMed ID: 3161209
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of plasminogen activation protects against ganglion cell loss in a mouse model of retinal damage.
    Zhang X, Chaudhry A, Chintala SK.
    Mol Vis; 2003 Jun 12; 9():238-48. PubMed ID: 12813409
    [Abstract] [Full Text] [Related]

  • 7. Characterization of a macrophage-derived plasminogen-activator inhibitor. Similarities with placental urokinase inhibitor.
    Chapman HA, Stone OL.
    Biochem J; 1985 Aug 15; 230(1):109-16. PubMed ID: 2932100
    [Abstract] [Full Text] [Related]

  • 8. Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants.
    Stephens RW, Pöllänen J, Tapiovaara H, Leung KC, Sim PS, Salonen EM, Rønne E, Behrendt N, Danø K, Vaheri A.
    J Cell Biol; 1989 May 15; 108(5):1987-95. PubMed ID: 2523891
    [Abstract] [Full Text] [Related]

  • 9. The behavior of alpha2-plasmin inhibitor in fibrinolytic states.
    Aoki N, Moroi M, Matsuda M, Tachiya K.
    J Clin Invest; 1977 Aug 15; 60(2):361-9. PubMed ID: 68962
    [Abstract] [Full Text] [Related]

  • 10. Sequence of formation of molecular forms of plasminogen and plasmin-inhibitor complexes in plasma activated by urokinase or tissue-type plasminogen activator.
    Thorsen S, Müllertz S, Suenson E, Kok P.
    Biochem J; 1984 Oct 01; 223(1):179-87. PubMed ID: 6208894
    [Abstract] [Full Text] [Related]

  • 11. Kinetics of the reaction between urokinase and an inhibitor of fibrinolysis from placental tissue.
    Christensen U, Holmberg L, Bladh B, Astedt B.
    Thromb Haemost; 1982 Aug 24; 48(1):24-6. PubMed ID: 6813991
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus.
    Glas-Greenwalt P, Kant KS, Allen C, Pollak VE.
    J Lab Clin Med; 1984 Dec 24; 104(6):962-76. PubMed ID: 6239000
    [Abstract] [Full Text] [Related]

  • 14. Interfering factors in the assay of plasminogen activators by the fibrin plate method. Occurrence of different inhibitors against tissue plasminogen activator and urokinase.
    Wijngaards G.
    Thromb Haemost; 1979 May 25; 41(3):590-600. PubMed ID: 111368
    [Abstract] [Full Text] [Related]

  • 15. Inactivation of the plasminogen activator from HeLa cells by peptides of arginine chloromethyl ketone.
    Coleman P, Kettner C, Shaw E.
    Biochim Biophys Acta; 1979 Jul 11; 569(1):41-51. PubMed ID: 111716
    [Abstract] [Full Text] [Related]

  • 16. The influence of the polyphenols of cider on plasmin and plasminogen activators.
    Ogston D, Lea AG, Langhorne P, Wilson SB.
    Br J Haematol; 1985 Aug 11; 60(4):705-13. PubMed ID: 3161536
    [Abstract] [Full Text] [Related]

  • 17. Detection and partial characterization of a specific plasminogen activator inhibitor in human chondrocyte cultures.
    Yamada H, Stephens RW, Nakagawa T, McNicol D.
    J Biochem; 1988 Dec 11; 104(6):960-7. PubMed ID: 3149640
    [Abstract] [Full Text] [Related]

  • 18. Identification of the human plasma protein which inhibits fibrinolysis associated with malignant cells.
    Collen D, Billiau A, Edy J, De Somer P.
    Biochim Biophys Acta; 1977 Sep 29; 499(2):194-201. PubMed ID: 198009
    [No Abstract] [Full Text] [Related]

  • 19. Complementary modes of action of tissue-type plasminogen activator and pro-urokinase by which their synergistic effect on clot lysis may be explained.
    Pannell R, Black J, Gurewich V.
    J Clin Invest; 1988 Mar 29; 81(3):853-9. PubMed ID: 2963831
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.